Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise Ultrasound Renal Denervation (RDN) system for the treatment of hypertension.
News | FDA
First FDA Approval of Renal Denervation System to Treat Hypertension Announced by Recor Medical and Otsuka Medical Devices

November 8, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U ...

Home November 08, 2023
Home
Smidt Heart Institute investigators say condition, apparent resistant hypertension, is common, and a particular medication may get patients’ disease under control
News | Hypertension
Novel Study Deepens Knowledge of Treatment-Resistant Hypertension

September 22, 2023 — For many patients with hypertension--an elevated blood pressure that can lead to stroke or heart ...

Home September 22, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Hypertension
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients

September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...

Home September 20, 2023
Home
All pregnant people should have their blood pressure measured at each prenatal visit
News | Hypertension
Task Force Issues Final Recommendation Statement on Screening for Hypertensive Disorders of Pregnancy

September 20, 2023 — The U.S. Preventive Services Task Force (Task Force) published a final recommendation statement on ...

Home September 20, 2023
Home
The analysis of the health records found that, on average, participants’ systolic blood pressure increased by up to 1.7 mm Hg in the winter months compared to the summer months
News | Hypertension
Study from AHA Hypertension Scientific Sessions Reports on Cold Weather’s Impact on Treating High Blood Pressure

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...

Home September 13, 2023
Home
Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).
News | Cardiovascular Clinical Studies
Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

Home September 12, 2023
Home
Recipient of the Harry Goldblatt Award for New Investigators from the American Heart Association’s 2023 Hypertension Council
News | Hypertension
Faulkner to be Honored by American Heart Association

September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...

Home September 07, 2023
Home
A new study in the AHA journal Hypertension finds SARS-CoV-2 infection is significantly associated with the development of high blood pressure in adults with preexisting heart conditions or those who were older, black or male.
News | Hypertension
Study Reveals COVID-19 May Trigger New-onset Hypertension

August 22, 2023 — An analysis of electronic medical records for more than 45,000 people found that COVID-19 infection ...

Home August 22, 2023
Home
The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on Renal Denervation (RDN), emphasizing patient selection, optimal techniques, competence, training, and institutional recommendations
News | Renal Denervation
New SCAI Position Statement Highlights the Role of Renal Denervation in Hypertension Treatment

August 21, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on ...

Home August 21, 2023
Home
New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040
News | Hypertension
Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

July 26, 2023 — Tenax Therapeutics, Inc, a specialty pharmaceutical company focused on identifying, developing and ...

Home July 26, 2023
Home
Research shows that patients have better outcomes when they are treated at an accredited center, such as the Hypertension Center in the Smidt Heart Institute, by physicians specialized in the disease. Photo by Getty.
News | Hypertension
Smidt Heart Institute’s Hypertension Center Earns Accreditation

July 25, 2023 — The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the A ...

Home July 25, 2023
Home
The results of a long-term analysis show necessary adjustments in international guidelines as well as in diagnosis and treatment
News | Hypertension
Chronic Thromboembolic Pulmonary Vascular Disease and Left Heart Disease are not Mutually Exclusive

April 28, 2023 — A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of ...

Home April 28, 2023
Home
Findings from a clinical trial on treating hypertension, published in the Journal of the American Medical Association (JAMA), highlight the potential of personalized medicine in cardiovascular care, and in the future, could improve treatment adherence, patient outcomes, and the cost-effectiveness of blood pressure-lowering medication.
News | Hypertension
Study on Blood Pressure Treatment Sheds Light on Value of Personalized Medicine in Cardiovascular Care

April 12, 2023 — Results from the Precision Hypertension Care Study (PHYSIC) showed that personalized blood pressure ...

Home April 12, 2023
Home
The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Association’s Hypertension journal.
News | Hypertension
Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

April 4, 2023 — The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood ...

Home April 04, 2023
Home
Royal Philips has announced the debut of a comprehensive approach to telehealth with Philips Virtual Care Management. The solution’s condition-specific protocols now include heart disease and hypertension, as well as other chronic conditions. Photo credit: Getty Images
News | Remote Monitoring
Philips Debuts Remote Patient Management Solution

March 28, 2023 — Royal Philips has announced its debut of Philips Virtual Care Management, a comprehensive approach to ...

Home March 28, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now